Dr. Nathan Price is (on leave) Professor at ISB, co-director of the Hood-Price Lab for Systems Biomedicine, and served as Associate Director of the Institute from 2013 to 2020. He is currently Chief Scientific Officer of Thorne HealthTech (NASDAQ: THRN). Previously he was CEO of Onegevity, an AI health intelligence company that merged with Thorne prior to its IPO in 2021. In 2019, he was named as one of the 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine, and in 2021 he was appointed to the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine. He is also co-author with Lee Hood of “The Age of Scientific Wellness” (Belknap Imprint of Harvard Press, 2023).
Dr. Price is Affiliate Faculty at the University of Washington in Bioengineering and Computer Science & Engineering. Previously he was an Assistant Professor at the University of Illinois, Urbana-Champaign in Chemical & Biomolecular Engineering and at the Institute for Genomic Biology. He is a Camille Dreyfus Teacher-Scholar, received the 2016 Grace A. Goldsmith award for his work pioneering “scientific wellness,” was a co-founder of Arivale, and received a Healthy Longevity Catalyst Award from the National Academy of Medicine in 2020. He has co-authored more than 200 peer-reviewed scientific publications and given over 200 talks and keynotes. He also served as Chair of the NIH Study Section on Modeling and Analysis of Biological Systems.
Dr. Price has won numerous awards for his work, including a Howard Temin Pathway to Independence Award from the National Institutes of Health, a National Science Foundation CAREER award, a young investigator award from the Roy J. Carver Charitable Trust, “Tomorrow’s PIs” from Genome Technology, a Camille Dreyfus Teacher-Scholar award, the Grace A. Goldsmith Award from the American College of Nutrition (given to one researcher each year under the age of 50, for his work pioneering “scientific wellness”), and is a National Academy of Medicine ELHM Scholar. In 2020, he was elected a fellow of the American Institute for Medical and Biological Engineering and received a Healthy Longevity Catalyst Award from the National Academy of Medicine for work on the microbiome and aging. He was also a finalist for the EY Entrepreneur of the Year for NY in 2021 and selected as one of the “Notables in Healthcare” by Crain’s New York in 2022.
He has also served on the Board of Trustees of the Health and Environmental Sciences Institute (HESI), the Pacific Northwest Board of Advisors for the American Cancer Society, and the Board for the University of Virginia’s Coulter Translational Research Partnership. Dr. Price has also served on numerous advisory boards including Roche (Personalized Healthcare Division), Providence St. Joseph Health, Sera Prognostics, Navican, Basepaws, Trelys, the Novo Nordisk Foundation Center for Biosustainability, and many others. Dr. Price served on the NAM committee to review omics-based tests for clinical trials.
PhD, Bioengineering, University of California, San Diego, 2005
Computational biology, biological networks, systems medicine, translational bioinformatics, scientific wellness